Lataa...

Nearly Pain-Free Self-administration of Subcutaneous Methotrexate With an Autoinjector: Results of a Phase 2 Clinical Trial in Patients With Rheumatoid Arthritis Who Have Functional Limitations

BACKGROUND: A methotrexate autoinjector (MTXAI) was developed for self-administration of subcutaneous (SC) methotrexate by patients with rheumatoid arthritis (RA). The MTXAI circumvents the need for vials, needles, and syringes and may therefore improve dosing accuracy, handling risks, and patient a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Freundlich, Bruce, Kivitz, Alan, Jaffe, Jonathan S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Lippincott Williams & Wilkins 2014
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4165470/
https://ncbi.nlm.nih.gov/pubmed/25036562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RHU.0000000000000117
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!